BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 22951697)

  • 1. [Local antibacterial therapy for the inflammatory diseases of the external and middle ear].
    Khon EM; Dzhenzhera GE; Ovchinnikov AIu
    Vestn Otorinolaringol; 2012; (3):92-4. PubMed ID: 22951697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drug therapy of otitis externa and otitis media].
    Okovityĭ SV; Ivkin DIu; Malygin SV
    Vestn Otorinolaringol; 2012; (1):52-6. PubMed ID: 22678642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The acceleration of remission after exacerbation of chronic suppurative otitis media following functional-reconstructive operations on the middle ear].
    Dvorianchikov VV; Kochergin GA; Syroezhin FA
    Vestn Otorinolaringol; 2012; (4):65-7. PubMed ID: 23011377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative characteristic of the local application of anti-inflammatory agents for the treatment of otitis externa and otitis media].
    Magomedov MM; Starostina AE; Magomedov MG
    Vestn Otorinolaringol; 2012; (5):69-72. PubMed ID: 23250533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of Dioxidine antimicrobial preparation for the treatment of inflammatory diseases of the external and middle ear].
    Ovchinnikov AY; Yeghian SS
    Vestn Otorinolaringol; 2016; 81(2):61-66. PubMed ID: 27213660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The current views of the treatment of diffuse external otitis].
    Fedorova OV; Shadrin GB
    Vestn Otorinolaringol; 2016; 81(3):51-53. PubMed ID: 27367351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The comparative study of the of clinical effectiveness of the Candibiotic, Otipax, and Anauran ear drops for the treatment of acute external and middle ear otitis].
    Kiselev AB; Chaukina VA
    Vestn Otorinolaringol; 2013; (6):76-8. PubMed ID: 24429865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of chronic otitis media in continuous or recurrent purulent discharge].
    Feĭgin GA
    Vestn Otorinolaringol; 2000; (1):15-7. PubMed ID: 10765714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The development of antibiotic resistant organisms with the use of ototopical medications.
    Weber PC; Roland PS; Hannley M; Friedman R; Manolidis S; Matz G; Owens F; Rybak L; Stewart MG
    Otolaryngol Head Neck Surg; 2004 Mar; 130(3 Suppl):S89-94. PubMed ID: 15054367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of topical ciprofloxacin/dexamethasone versus neomycin/polymyxin B/hydrocortisone for otitis externa.
    Roland PS; Pien FD; Schultz CC; Henry DC; Conroy PJ; Wall GM; Garadi R; Dupre SJ; Potts SL; Hogg LG; Stroman DW;
    Curr Med Res Opin; 2004 Aug; 20(8):1175-83. PubMed ID: 15324520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candid-B cream in the treatment of candidiasis with inflammatory dermatoses--National Study Group.
    Wadhwa SL; Thomas J; Ainapure SS; Desai A
    J Indian Med Assoc; 2000 Sep; 98(9):580, 582. PubMed ID: 11291799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pooled analysis of two clinical trials comparing the clinical outcomes of topical ciprofloxacin/dexamethasone otic suspension and polymyxin B/neomycin/hydrocortisone otic suspension for the treatment of acute otitis externa in adults and children.
    Rahman A; Rizwan S; Waycaster C; Wall GM
    Clin Ther; 2007 Sep; 29(9):1950-6. PubMed ID: 18035194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy and safety of topical combination therapy in patients with acute otitis externa].
    Gurov AV; Kriukov AI; Shadrin GB; Izotova GN; Zotova PK
    Ter Arkh; 2023 Dec; 95(11):937-942. PubMed ID: 38158949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Our experience using triderm for the treatment of external otitis].
    Vakhrushev SG; Pronina IuV; Zyrianov MM; Bugakova TM
    Vestn Otorinolaringol; 2004; (4):42-3. PubMed ID: 15496842
    [No Abstract]   [Full Text] [Related]  

  • 15. [Suppurative chronic otitis media: etiology, diagnosis and therapy].
    Reiss M; Reiss G
    Med Monatsschr Pharm; 2010 Jan; 33(1):11-6; quiz 17-8. PubMed ID: 20131670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experience with the application of Kombinil-Duo ear drops for the treatment of diffuse external otitis media].
    Khrappo NS; Miroshnichenko AP; Strunina EIu
    Vestn Otorinolaringol; 2013; (6):72-5. PubMed ID: 24429864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is biofilm the cause of chronic otitis externa?
    Fusconi M; Petrozza V; Taddei AR; Vinciguerra V; De Virgilio A; Chiarini F; Cirenza M; Gallinelli C; Conte M; de Vincentiis M
    Laryngoscope; 2011 Dec; 121(12):2626-33. PubMed ID: 22109763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. External auditory canal cholesteatoma and benign necrotising otitis externa: clinical study of 95 cases in the Capital Region of Denmark.
    Hertz J; Siim C
    J Laryngol Otol; 2018 Jun; 132(6):514-518. PubMed ID: 29888691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A group III steroid solution without antibiotic components: an effective cure for external otitis.
    Emgård P; Hellström S
    J Laryngol Otol; 2005 May; 119(5):342-7. PubMed ID: 15949095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of two antimicrobial/anti-inflammatory formulations in the treatment of canine otitis externa.
    Rougier S; Borell D; Pheulpin S; Woehrlé F; Boisramé B
    Vet Dermatol; 2005 Oct; 16(5):299-307. PubMed ID: 16238809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.